Famvir

Famvir Use In Pregnancy & Lactation

famciclovir

Manufacturer:

Atnahs

Distributor:

DKSH
Full Prescribing Info
Use In Pregnancy & Lactation
Women of child-bearing potential: There are no data supporting any special recommendations in women of child-bearing potential.
Pregnancy: Although animal studies have not shown any embryotoxic or teratogenic effects with famciclovir or penciclovir (the active metabolite of famciclovir), there are insufficient data on the use of Famvir in pregnant women. Famvir should, therefore, not be used during pregnancy unless the potential benefits are considered to outweigh the potential risks associated with treatment.
Breast-feeding: Following oral administration of famciclovir to lactating rats, penciclovir was excreted in breast milk. There is no information on excretion in human milk. Famvir should not be used in nursing mothers unless the potential benefits are considered to outweigh the potential risks associated with treatment.
Fertility: Famciclovir has been shown to have no significant effects on sperm count, morphology or motility in man. Clinical data do not indicate an impact of famciclovir on male fertility following long-term treatment at an oral dose of 250 mg twice daily.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in